Showing all 17 results

  • ariply 10

    ARIPLY 10 – Aripiprazole

    For treatment of schizophrenia.
    For treatment of moderate to severe manic states in bipolar disorder type 1
    and for the prevention of new manic episodes in patients who predominantly
    experienced manic episodes and who had previous manic episodes that responded
    to aripiprazole treatment.
    In addition, Ariply 5, 10, 15 are intended:
    For combined treatment in major depressive disorder (MDD) for patients who
    experienced a partial response to therapy.
    For treatment of restlessness associated with an autistic disorder in children
    (ages 6-17).


    ARIPLY 10 – Aripiprazole

    For treatment of schizophrenia. For treatment of moderate to severe manic states in bipolar disorder type 1 and for the prevention of new manic episodes in patients who predominantly experienced manic episodes and who had previous manic episodes that responded to aripiprazole treatment. In addition, Ariply 5, 10, 15 are intended: For combined treatment in major depressive disorder (MDD) for patients who experienced a partial response to therapy. For treatment of restlessness associated with an autistic disorder in children (ages 6-17).

    Read More

  • ariply 15

    ARIPLY 15 – Aripiprazole

    For treatment of schizophrenia.
    For treatment of moderate to severe manic states in bipolar disorder type 1
    and for the prevention of new manic episodes in patients who predominantly
    experienced manic episodes and who had previous manic episodes that responded
    to aripiprazole treatment.
    In addition, Ariply 5, 10, 15 are intended:
    For combined treatment in major depressive disorder (MDD) for patients who
    experienced a partial response to therapy.
    For treatment of restlessness associated with an autistic disorder in children
    (ages 6-17).


    ARIPLY 15 – Aripiprazole

    For treatment of schizophrenia. For treatment of moderate to severe manic states in bipolar disorder type 1 and for the prevention of new manic episodes in patients who predominantly experienced manic episodes and who had previous manic episodes that responded to aripiprazole treatment. In addition, Ariply 5, 10, 15 are intended: For combined treatment in major depressive disorder (MDD) for patients who experienced a partial response to therapy. For treatment of restlessness associated with an autistic disorder in children (ages 6-17).

    Read More

  • ariply 30

    ARIPLY 30 – Aripiprazole

    For treatment of schizophrenia.
    For treatment of moderate to severe manic states in bipolar disorder type 1
    and for the prevention of new manic episodes in patients who predominantly
    experienced manic episodes and who had previous manic episodes that responded
    to aripiprazole treatment.
    In addition, Ariply 5, 10, 15 are intended:
    For combined treatment in major depressive disorder (MDD) for patients who
    experienced a partial response to therapy.
    For treatment of restlessness associated with an autistic disorder in children
    (ages 6-17).


    ARIPLY 30 – Aripiprazole

    For treatment of schizophrenia. For treatment of moderate to severe manic states in bipolar disorder type 1 and for the prevention of new manic episodes in patients who predominantly experienced manic episodes and who had previous manic episodes that responded to aripiprazole treatment. In addition, Ariply 5, 10, 15 are intended: For combined treatment in major depressive disorder (MDD) for patients who experienced a partial response to therapy. For treatment of restlessness associated with an autistic disorder in children (ages 6-17).

    Read More

  • ariply 5

    ARIPLY 5 – Aripiprazole

    For treatment of schizophrenia.
    For treatment of moderate to severe manic states in bipolar disorder type 1
    and for the prevention of new manic episodes in patients who predominantly
    experienced manic episodes and who had previous manic episodes that responded
    to aripiprazole treatment.
    In addition, Ariply 5, 10, 15 are intended:
    For combined treatment in major depressive disorder (MDD) for patients who
    experienced a partial response to therapy.
    For treatment of restlessness associated with an autistic disorder in children
    (ages 6-17).


    ARIPLY 5 – Aripiprazole

    For treatment of schizophrenia. For treatment of moderate to severe manic states in bipolar disorder type 1 and for the prevention of new manic episodes in patients who predominantly experienced manic episodes and who had previous manic episodes that responded to aripiprazole treatment. In addition, Ariply 5, 10, 15 are intended: For combined treatment in major depressive disorder (MDD) for patients who experienced a partial response to therapy. For treatment of restlessness associated with an autistic disorder in children (ages 6-17).

    Read More

  • pericate 100

    PERICATE – Haloperidol

    For the maintenance therapy of schizophrenic patients


    PERICATE – Haloperidol

    For the maintenance therapy of schizophrenic patients

    Read More

  • pride 100

    PRIDE 100 – Amisulpride

    The medicine is intended to treat schizophrenia


    PRIDE 100 – Amisulpride

    The medicine is intended to treat schizophrenia

    Read More

  • pride 400

    PRIDE 400 – Amisulpride

    The medicine is intended to treat schizophrenia


    PRIDE 400 – Amisulpride

    The medicine is intended to treat schizophrenia

    Read More

  • rispond 1

    RISPOND 1 – Risperidone

    For the treatment of schizophrenia and symptoms
    of psychotic disorders.
    – For long-term treatment in order to sustain the
    improvement in the state of the illness in patients
    who have exhibited an initial response.
    – For the treatment of psychotic manifestations of
    moderate to severe dementia, only in Alzheimer’s
    disease (short-term treatment up to 6 weeks in
    a situation of consistent aggression), in patients
    who are not responding to non-pharmacological
    treatment and there is concern that they will harm
    themselves or others.
    – For treatment of mania in bipolar disorder.
    – For the treatment of behavioral disorders such
    as violence, impulsiveness and self aggression in
    children over 5 years of age and in adults who are
    intellectually handicapped.


    RISPOND 1 – Risperidone

    For the treatment of schizophrenia and symptoms of psychotic disorders. – For long-term treatment in order to sustain the improvement in the state of the illness in patients who have exhibited an initial response. – For the treatment of psychotic manifestations of moderate to severe dementia, only in Alzheimer’s disease (short-term treatment up to 6 weeks in a situation of consistent aggression), in patients who are not responding to non-pharmacological treatment and there is concern that they will harm themselves or others. – For treatment of mania in bipolar disorder. – For the treatment of behavioral disorders such as violence, impulsiveness and self aggression in children over 5 years of age and in adults who are intellectually handicapped.

    Read More

  • rispond 2

    RISPOND 2 – Risperidone

    For the treatment of schizophrenia and symptoms
    of psychotic disorders.
    – For long-term treatment in order to sustain the
    improvement in the state of the illness in patients
    who have exhibited an initial response.
    – For the treatment of psychotic manifestations of
    moderate to severe dementia, only in Alzheimer’s
    disease (short-term treatment up to 6 weeks in
    a situation of consistent aggression), in patients
    who are not responding to non-pharmacological
    treatment and there is concern that they will harm
    themselves or others.
    – For treatment of mania in bipolar disorder.
    – For the treatment of behavioral disorders such
    as violence, impulsiveness and self aggression in
    children over 5 years of age and in adults who are
    intellectually handicapped.


    RISPOND 2 – Risperidone

    For the treatment of schizophrenia and symptoms of psychotic disorders. – For long-term treatment in order to sustain the improvement in the state of the illness in patients who have exhibited an initial response. – For the treatment of psychotic manifestations of moderate to severe dementia, only in Alzheimer’s disease (short-term treatment up to 6 weeks in a situation of consistent aggression), in patients who are not responding to non-pharmacological treatment and there is concern that they will harm themselves or others. – For treatment of mania in bipolar disorder. – For the treatment of behavioral disorders such as violence, impulsiveness and self aggression in children over 5 years of age and in adults who are intellectually handicapped.

    Read More

  • rispond 3

    RISPOND 3 – Risperidone

    For the treatment of schizophrenia and symptoms
    of psychotic disorders.
    – For long-term treatment in order to sustain the
    improvement in the state of the illness in patients
    who have exhibited an initial response.
    – For the treatment of psychotic manifestations of
    moderate to severe dementia, only in Alzheimer’s
    disease (short-term treatment up to 6 weeks in
    a situation of consistent aggression), in patients
    who are not responding to non-pharmacological
    treatment and there is concern that they will harm
    themselves or others.
    – For treatment of mania in bipolar disorder.
    – For the treatment of behavioral disorders such
    as violence, impulsiveness and self aggression in
    children over 5 years of age and in adults who are
    intellectually handicapped.


    RISPOND 3 – Risperidone

    For the treatment of schizophrenia and symptoms of psychotic disorders. – For long-term treatment in order to sustain the improvement in the state of the illness in patients who have exhibited an initial response. – For the treatment of psychotic manifestations of moderate to severe dementia, only in Alzheimer’s disease (short-term treatment up to 6 weeks in a situation of consistent aggression), in patients who are not responding to non-pharmacological treatment and there is concern that they will harm themselves or others. – For treatment of mania in bipolar disorder. – For the treatment of behavioral disorders such as violence, impulsiveness and self aggression in children over 5 years of age and in adults who are intellectually handicapped.

    Read More

  • rispond-4-eng

    RISPOND 4 – Risperidone

    For the treatment of schizophrenia and symptoms
    of psychotic disorders.
    – For long-term treatment in order to sustain the
    improvement in the state of the illness in patients
    who have exhibited an initial response.
    – For the treatment of psychotic manifestations of
    moderate to severe dementia, only in Alzheimer’s
    disease (short-term treatment up to 6 weeks in
    a situation of consistent aggression), in patients
    who are not responding to non-pharmacological
    treatment and there is concern that they will harm
    themselves or others.
    – For treatment of mania in bipolar disorder.
    – For the treatment of behavioral disorders such
    as violence, impulsiveness and self aggression in
    children over 5 years of age and in adults who are
    intellectually handicapped.


    RISPOND 4 – Risperidone

    For the treatment of schizophrenia and symptoms of psychotic disorders. – For long-term treatment in order to sustain the improvement in the state of the illness in patients who have exhibited an initial response. – For the treatment of psychotic manifestations of moderate to severe dementia, only in Alzheimer’s disease (short-term treatment up to 6 weeks in a situation of consistent aggression), in patients who are not responding to non-pharmacological treatment and there is concern that they will harm themselves or others. – For treatment of mania in bipolar disorder. – For the treatment of behavioral disorders such as violence, impulsiveness and self aggression in children over 5 years of age and in adults who are intellectually handicapped.

    Read More

  • rispond solution

    RISPOND ORAL SOLUTION

    For the treatment of schizophrenia and symptoms
    of psychotic disorders.
    – For long-term treatment in order to sustain the
    improvement in the state of the illness in patients
    who have exhibited an initial response.
    – For the treatment of psychotic manifestations of
    moderate to severe dementia, only in Alzheimer’s
    disease (short-term treatment up to 6 weeks in
    a situation of consistent aggression), in patients
    who are not responding to non-pharmacological
    treatment and there is concern that they will harm
    themselves or others.
    – For treatment of mania in bipolar disorder.
    – For the treatment of behavioral disorders such
    as violence, impulsiveness and self aggression in
    children over 5 years of age and in adults who are
    intellectually handicapped.


    RISPOND ORAL SOLUTION

    For the treatment of schizophrenia and symptoms of psychotic disorders. – For long-term treatment in order to sustain the improvement in the state of the illness in patients who have exhibited an initial response. – For the treatment of psychotic manifestations of moderate to severe dementia, only in Alzheimer’s disease (short-term treatment up to 6 weeks in a situation of consistent aggression), in patients who are not responding to non-pharmacological treatment and there is concern that they will harm themselves or others. – For treatment of mania in bipolar disorder. – For the treatment of behavioral disorders such as violence, impulsiveness and self aggression in children over 5 years of age and in adults who are intellectually handicapped.

    Read More

  • zappa 10

    ZAPPA 10 – Olanzapine

    An antipsychotic preparation for treatment of schizophrenia
    and symptoms of psychotic disorders. In addition, it is intended
    to treat bipolar affective disorder.


    ZAPPA 10 – Olanzapine

    An antipsychotic preparation for treatment of schizophrenia and symptoms of psychotic disorders. In addition, it is intended to treat bipolar affective disorder.

    Read More

  • zappa 5

    ZAPPA 5 – Olanzapine

    An antipsychotic preparation for treatment of schizophrenia
    and symptoms of psychotic disorders. In addition, it is intended
    to treat bipolar affective disorder.


    ZAPPA 5 – Olanzapine

    An antipsychotic preparation for treatment of schizophrenia and symptoms of psychotic disorders. In addition, it is intended to treat bipolar affective disorder.

    Read More

  • zappa 7.5

    ZAPPA 7.5 – Olanzapine

    An antipsychotic preparation for treatment of schizophrenia
    and symptoms of psychotic disorders. In addition, it is intended
    to treat bipolar affective disorder.


    ZAPPA 7.5 – Olanzapine

    An antipsychotic preparation for treatment of schizophrenia and symptoms of psychotic disorders. In addition, it is intended to treat bipolar affective disorder.

    Read More

  • zappa odt 5

    ZAPPA ODT 5 – Olanzapine

    An antipsychotic preparation for treatment of schizophrenia
    and symptoms of psychotic disorders. In addition, it is intended
    to treat bipolar affective disorder.


    ZAPPA ODT 5 – Olanzapine

    An antipsychotic preparation for treatment of schizophrenia and symptoms of psychotic disorders. In addition, it is intended to treat bipolar affective disorder.

    Read More

  • zappa odt 10

    ZAPPA ODT10 – Olanzapine

    An antipsychotic preparation for treatment of schizophrenia
    and symptoms of psychotic disorders. In addition, it is intended
    to treat bipolar affective disorder.


    ZAPPA ODT10 – Olanzapine

    An antipsychotic preparation for treatment of schizophrenia and symptoms of psychotic disorders. In addition, it is intended to treat bipolar affective disorder.

    Read More